BETA PHARMA, INC.
16Patents
15Active
16Granted
46Portfolio score
Filing activity: Mar 26, 2003 → Nov 12, 2021 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7078409B2 | Fused quinazoline derivatives useful as tyrosine kinase inhibitors | Chemistry; Metallurgy | 5 | Expired |
| US10239864B2 | 2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof | Human Necessities | 3 | Active |
| US9878994B2 | 2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof | Human Necessities | 3 | Active |
| US8822482B2 | Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10590111B2 | Substituted 2-anilinopyrimidine derivatives as EGFR modulators | Chemistry; Metallurgy | 1 | Active |
| US9359370B2 | Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9163010B2 | Indolinone protein kinase inhibitors | Human Necessities | 0 | Active |
| US11352341B2 | 2H-indazole derivatives as CDK4 and CDK6 inhibitors and therapeutic uses thereof | Human Necessities | 0 | Active |
| US10844045B2 | Pharmaceutical salts N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and crystalline forms thereof | Chemistry; Metallurgy | 0 | Active |
| US11180478B2 | Pharmaceutical formulations of N-(2-(2-(dimethylamino) ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and salts thereof | Chemistry; Metallurgy | 0 | Active |
| US12390464B2 | Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 inhibitors | Human Necessities | 0 | Active |
| US12187707B2 | Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylaminde and salts thereof | Chemistry; Metallurgy | 0 | Active |
| US11414401B2 | Substituted 2-anilinopyrimidine derivatives as EGFR modulators | Chemistry; Metallurgy | 0 | Active |
| US12258365B2 | Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses thereof | Human Necessities | 0 | Active |
| US11052086B2 | 2-anilinopyrimidine derivatives as therapeutic agents for treatment of brain cancers | Human Necessities | 0 | Active |
| US9820721B2 | Aspiration and biopsy needle apparatus and devices and applications thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.